Skip to main content
HeartCited

Berberine için Metabolic Syndrome (Cardiovascular Aspects)

B Kanıt Bunu büyük ölçüde tutarlı sonuçlarla en az bir randomize çalışma desteklemektedir.

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome\u002Dcardiovascular'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
Sonuç

            
            
Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Other
                
                
                
                6 weeks
                
                
            

            
                Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
            
            

                
                Dose: None
                
                
                vs: MCD diet MASH model; Abx + FMT experiments
                
                
                Outcome: Hepatic/colonic inflammation, Akkermansia abundance
                
                
                Etki: None
                
                
                None
                
            

            
            
Popülasyon: MCD diet-induced MASH C57BL/6J male mice

            
        

        
        

            

                
                    Other
                
                
                
                
            

            
                The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with …
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: None
                
                
                Etki: None
                
                
                None
                
            

            
            
Popülasyon: None

            
        

        
        

            

                
                    Systematic Review
                
                
                n=61
                
                
                
            

            
                Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: None
                
                
                Etki: None
                
                
                None
                
            

            
            
Popülasyon: Alzheimer's disease patients

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
20

        
Çalışmalar

    

    

        
2500

        
Katılımcılar

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
Derece

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        The Journal of …
                        2025
                        
                        1 atıf
                        
                    

                

                
                

                    

                        
                            The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in …
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        Brazilian journal of …
                        2022
                        
                        12 atıf
                        
                    

                

                
                

                    

                        
                            Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
                        
                        
                            
                                Systematic Review
                            
                            
                            
                        
                    

                    

                        Journal of integrative …
                        2020
                        
                        33 atıf
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Yaygın Kullanılan Dozajlar

                

                    
                    

                        
general:

                        
500-1,500 mg/day divided TID

                    

                    
                    

                        
lipidsupport:

                        
500 mg TID with meals

                    

                    
                

                
                

                    Üst sınır: Not formally established; GI side effects limit doses >1,500 mg/day
                

                
            

            

            
            

                
Araştırmalarda İncelenen Dozajlar

                

                    

                        
                            

                                Dozaj
                                Süre
                                Etki
                                N
                            

                        
                        
                            
                            

                                None
                                6 weeks
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                61
                            

                            
                        
                    

                

            

            

            
            

                En iyi alım zamanı: With meals, divided TID for sustained plasma levels; short half-life
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Bildirilen Yan Etkiler

                    
    
                        
                        
  • 
                            ⚠
                            Diarrhea (most common, usually resolves in 2 weeks)
                        
    • 
                        
                        
  • 
                            ⚠
                            Constipation
                        
    • 
                        
                        
  • 
                            ⚠
                            Flatulence
                        
    • 
                        
                        
  • 
                            ⚠
                            Abdominal pain
                        
    • 
                        
                        
  • 
                            ⚠
                            May lower blood sugar (monitor in diabetics)
                        
    • 
                        
                    

                

                

                
                

                    
Bilinen Etkileşimler

                    
    
                        
                        
  • 
                            ●
                            Metformin (additive blood sugar lowering; may increase metformin levels)
                        
    • 
                        
                        
  • 
                            ●
                            CYP2D6 and CYP3A4 substrates (berberine is a CYP inhibitor)
                        
    • 
                        
                        
  • 
                            ●
                            Cyclosporine (may increase blood levels)
                        
    • 
                        
                        
  • 
                            ●
                            Macrolide antibiotics (may prolong QT interval)
                        
    • 
                        
                        
  • 
                            ●
                            Statins (complementary mechanism; monitor for additive effects)
                        
    • 
                        
                    

                

                

                
                

                    

                        Tolere edilebilir üst alım: Not formally established; GI side effects limit doses >1,500 mg/day
                    

                

                
            

            

                Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Berberine help with Metabolic Syndrome (Cardiovascular Aspects)?
            
        
        

            Based on 20 studies with 2,500 participants, there is moderate evidence from clinical studies that Berberine may support Metabolic Syndrome (Cardiovascular Aspects) management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Berberine should I take for Metabolic Syndrome (Cardiovascular Aspects)?
            
        
        

            Studies have used various dosages. A commonly studied range is 500-1,500 mg/day divided TID. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Berberine?
            
        
        

            Reported side effects may include Diarrhea (most common, usually resolves in 2 weeks), Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Berberine and Metabolic Syndrome (Cardiovascular Aspects)?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                

                
                
                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Jiahui Xu et al..
      J Nutr Biochem.
      2025.
      Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
      doi:10.1016/j.jnutbio.2025.110069
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Yufan Dai et al..
      Braz J Med Biol Res.
      2022.
      The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in …
      doi:10.1590/1414-431X2022e12096
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Noriko Shinjyo et al..
      J Integr Med.
      2020.
      Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
      doi:10.1016/j.joim.2020.01.004
      PubMed
    
    4. 
    
  















    

        FDA Sorumluluk Reddi:
        Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.